I've posted this somewhere else, but I'll post again. I recently found out that the manufacturers "cost" of drugs is 10% of what they charge a hospital/infusion center/pharmacy/ and then the markup begins.... In the case of Tysabri in MT, the "cost" is $400, the hospitals pay $4000, and then the markup begins...One hospital charges over $17,000 per month for Ty. Research/development is only 1-3% of a company's budget. They are more than compensated for any new drugs. The patent runs until 2028, so they'll do well. That said, I am grateful for all new MS drugs that hit the market. However, I try to keep their "cost" in the back of my mind.

Comment